Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Interplay of macrophages and T cells in the lung vasculature.

Gerasimovskaya E, Kratzer A, Sidiakova A, Salys J, Zamora M, Taraseviciene-Stewart L.

Am J Physiol Lung Cell Mol Physiol. 2012 May 15;302(10):L1014-22. doi: 10.1152/ajplung.00357.2011. Epub 2012 Mar 2.

2.

The pathobiology of pulmonary hypertension. Endothelium.

Tuder RM, Cool CD, Yeager M, Taraseviciene-Stewart L, Bull TM, Voelkel NF.

Clin Chest Med. 2001 Sep;22(3):405-18. Review.

PMID:
11590837
3.

Reversible or irreversible remodeling in pulmonary arterial hypertension.

Sakao S, Tatsumi K, Voelkel NF.

Am J Respir Cell Mol Biol. 2010 Dec;43(6):629-34. doi: 10.1165/rcmb.2009-0389TR. Epub 2009 Dec 11. Review.

4.

Challenges and opportunities in treating inflammation associated with pulmonary hypertension.

Voelkel NF, Tamosiuniene R, Nicolls MR.

Expert Rev Cardiovasc Ther. 2016 Aug;14(8):939-51. doi: 10.1080/14779072.2016.1180976. Epub 2016 May 4. Review.

5.

Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension.

Rabinovitch M, Guignabert C, Humbert M, Nicolls MR.

Circ Res. 2014 Jun 20;115(1):165-75. doi: 10.1161/CIRCRESAHA.113.301141. Review.

6.

Regulatory T cells and pulmonary hypertension.

Tamosiuniene R, Nicolls MR.

Trends Cardiovasc Med. 2011 Aug;21(6):166-71. doi: 10.1016/j.tcm.2012.05.004. Review.

Supplemental Content

Support Center